A recent study reveals that patients who come off blockbuster weight-loss injections like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who halt traditional diet and exercise plans.
Published data in a major medical journal shows that while overweight individuals frequently drop a large proportion of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing such medications must be cognizant of the danger of fast rebound weight gain when the treatment concludes," warns lead investigator Dr. Susan Jebb.
This pace of recovery suggests a return to pre-treatment weight within about 18 months.
Analyzing Therapies
The study, which examined 37 of studies involving over 9,000 of participants, compared the outcomes of these new drugs with older methods.
Scientists point out that individuals who shed pounds through dieting usually see a more gradual creep back—approximately 0.1 kg a month—after stopping.
Understanding the Rapid Rebound
Nutrition scientists suggest the way of the jabs explains the heightened rebound.
These medications mimic a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Artificially providing the hormone concentrations far above than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication leads to hunger is no longer kept in check, making binge eating far more likely."
An Ongoing Condition?
Medical guidelines advise the jabs for individuals with obesity-related health risks, accompanied by recommended lifestyle changes.
A number of clinicians say that, given the high risk of weight regain, the treatment should be considered life-long.
This opinion is echoed by pharmaceutical companies, who state that the results "highlight the long-term character of obesity," comparing it to managing conditions like diabetes.
Patient Testimonies
People who have discontinued the medication explain a intense return of hunger.
"I experienced something activating and you're instantly ravenous," recalled a patient.
This challenge is exacerbated if patients have not established lasting dietary or behavioural modifications during treatment.
Significant Interest
Survey data indicate that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.
- Use is greater among women than men.
- The 40s and 50s age group shows the highest level of interest.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts caution that while GLP-1 drugs are powerful agents for weight loss, they are not a permanent fix and lasting health benefits relies on combined lifestyle changes.
